The Role: This position is an exciting opportunity to work with a computational biologist to assist in the application and development of data analysis tools for RNA structure analysis and other next-generation sequencing (NGS) data. These efforts support a wide variety of departments and the advancement of Moderna’s mRNA therapeutics platform. Candidates strong in either Biology or Computer Science with some experience in the other are encouraged to apply. Helpful but not required is knowledge of statistics, NGS, cloud computing (especially Amazon Web Services), Docker, and code testing – we can teach you as we go. Here’s What You’ll Do: Assist in development and improvement of standard visualizations for complex NGS data. Contribute to benchmarking statistical tools. Specifically, you will work with a mentor to develop standard reports and develop intuitive exploratory visualizations Benchmark statistical tools Create tests Add Docker support Make reports more intuitive and useful to end users Attend meetings with data creators and experiment designers to better understand end-user needs. Meet weekly (or more, if you prefer) with your mentor for guidance and collaboration. Present at least once to the Bioinformatics team. Here’s What You’ll Bring to the Table: Minimum GPA of 3.4 Major: Biology, Biochemistry or similar; or Computer Science or similar. Programming experience required; Python experience preferred. Coursework in statistics a plus. Previous co-op or intern experience preferred. Must be curious, eager, open to learning, and independent. Here’s What We’ll Bring to the Table: On-site subsidized cafeteria or catered lunches Free parking, monthly subway pass or a subsidized commuter rail pass Free annual corporate membership to Bluebikes Highly competitive healthcare coverage including: medical offered through BCBS (HMO/PPO), dental, and vision offered through VSP Flexible Spending Accounts for medical expenses and dependent care expenses About Moderna: Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. The Company’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing Moderna the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators. Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca, Plc. and Merck, Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense, the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) and the Coalition for Epidemic Preparedness Innovations (CEPI). Moderna has been ranked in the top ten of Science’s list of top biopharma industry employers for the past five years. To learn more, visit www.modernatx.com. Our Mission: Deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. Moderna is a smoke-free, alcohol-free and drug-free work environment. Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Moderna will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law. #LI-KP1
